Area of research
Hematology · Epidemiology
Research interest
Research interests include Multiple Myeloma Research and Treatments, Respiratory viral infections research, Lymphoma Diagnosis and Treatment, and Cancer Treatment and Pharmacology.
Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors—Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)
HDP-101: Preclinical evaluation of a novel anti-BCMA antibody drug conjugates in multiple myeloma.
Oncogene-induced senescence: a potential breakpoint mechanism against malignant transformation in plasma cell disorders
Profiling of Oncogenic Signaling in Multiple Myeloma — Association with Biology, Disease Progression and Prognosis
Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)
Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activation
Isavuconazole shortens the QTc interval
Analysis of long‐term survival in multiple myeloma after first‐line autologous stem cell transplantation: impact of clinical risk factors and sustained response
Pretransplant Vitamin D Deficiency Is Associated With Higher Relapse Rates in Patients Allografted for Myeloid Malignancies
Preclinical Evaluation of Hdp-101, a Novel Anti-BCMA Antibody-Drug Conjugate, in Multiple Myeloma
Analysis of prognostic factors in patients with newly diagnosed diffuse large B-cell lymphoma and skeletal involvement
Comprehensive Genomic Characterization of Refractory Multiple Myeloma Reveals a Complex Mutational and Structural Landscape Associated with Drug Resistance
Community acquired respiratory virus infections in cancer patients—Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology
Spatially divergent clonal evolution in multiple myeloma: overcoming resistance to BRAF inhibition
Influenza virus infections in patients with malignancies –– characteristics and outcome of the season 2014/15. A survey conducted by the Infectious Diseases Working Party (AGIHO) of the German Society of Haematology and Medical Oncology (DGHO)
Abstract 2283: Molecular signaling in multiple myeloma: association of RAS/RAF mutation status and MAPK pathway activation in primary myeloma patient biopsies
Analysis of Long-Term Survival in Multiple Myeloma Patients after First-Line Autologous Stem Cell Transplantation: Impact of Clinical Risk Factors and Duration of Response
Abstract 2423: Signaling pathway profiling in multiple myeloma
Signaling Pathway Profiling in Multiple Myeloma
Targeting the BRAF V600E Mutation in Multiple Myeloma
Risk factors and containment of respiratory syncytial virus outbreak in a hematology and transplant unit
Continued Response Off Treatment After BRAF Inhibition in Refractory Hairy Cell Leukemia
Autologous retransplantation for patients with recurrent multiple myeloma
Expression of Mucin‐1 in multiple myeloma and its precursors: correlation with glycosylation and subcellular localization
Impact Of Response Duration and Maintenance Therapy After Autologous Stem Cell Transplantation On Long-Term Survival In Multiple Myeloma Patients
The Chromosomal Abnormalities Del(17p), t(4;14), and +1q21 Predict Progression From Smoldering to Symptomatic Multiple Myeloma
BRAF V600E Mutations in Multiple Myeloma: Clinical and Therapeutic Implications
Autologous Re-Transplantation for Patients with Relapsed Multiple Myeloma: A Single Center Experience with 200 Patients.
Continued Response off Treatment After BRAF Inhibition in Refractory Hairy Cell Leukemia